Clinical Trial: Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07540949) titled 'Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity' on April 12.

Brief Summary: This study evaluates whether a fruit- and vegetable-based fermented product (Rutazyme(R) lemon fermented product) taken as a capsule can improve metabolic health in adults with obesity. Forty adults aged 18-65 years with obesity (BMI >= 27 kg/m² and waist circumference > 90 cm for men or > 80 cm for women) will be randomly assigned to receive either a Rutazyme(R) lemon fermented product capsule (500 mg) or a placebo capsule once daily at bedtime for 12 weeks. Before supplementation, participants will complete a ...